Esperion Therapeutics Inc. (NASDAQ: ESPR) stock closed at 6.55 per share at the end of the most recent trading day (a 1.24% change compared to the prior day closing price) with a volume of 683.99K shares and market capitalization of 395.05M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 479 people. Esperion Therapeutics Inc. CEO is Timothy M. Mayleben.

The one-year performance of Esperion Therapeutics Inc. stock is -70.91%, while year-to-date (YTD) performance is 31%. ESPR stock has a five-year performance of -86.43%. Its 52-week range is between 3.28 and 23.75, which gives ESPR stock a 52-week price range ratio of 14.61%

Esperion Therapeutics Inc. currently has a PE ratio of -1.00, a price-to-book (PB) ratio of 80.52, a price-to-sale (PS) ratio of 4.62, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -77.53%, a ROC of -194.99% and a ROE of 93.32%. The company’s profit margin is -66.86%, its EBITDA margin is -203.80%, and its revenue ttm is $89.31 Million , which makes it $1.42 revenue per share.

Of the last four earnings reports from Esperion Therapeutics Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.95 for the next earnings report. Esperion Therapeutics Inc.’s next earnings report date is 02nd Aug 2022.

The consensus rating of Wall Street analysts for Esperion Therapeutics Inc. is Hold (2.79), with a target price of $11.22, which is +78.95% compared to the current price. The earnings rating for Esperion Therapeutics Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Esperion Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Esperion Therapeutics Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.79, ATR14 : 0.42, CCI20 : 167.60, Chaikin Money Flow : 0.15, MACD : 0.13, Money Flow Index : 69.03, ROC : 7.38, RSI : 61.50, STOCH (14,3) : 95.53, STOCH RSI : 1.00, UO : 61.57, Williams %R : -4.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Esperion Therapeutics Inc. in the last 12-months were: Eric Warren (Sold 452 shares of value $2 427 ), J. Martin Carroll (Buy at a value of $28 180), Sheldon L. Koenig (Sold 5 694 shares of value $27 949 )